PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)-Reference-Cited by-同舟云学术

PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)

Published:2020-08-06 Issue:4 Volume:20 Page:1-1
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Loizzi Vera¹,Ranieri Girolamo²,Laforgia Mariarita³,Gadaleta Cosmo ²,Gargano Giulio⁴,Kardhashi Anila⁴,De Liso Maria⁴,Naglieri Emanuele⁵,Del Vecchio Vittoria¹,Cicinelli Ettore¹,Cormio Gennaro¹

Affiliation:

1. Department of Biomedical Sciences and Human Oncology, University of Bari, I‑70121 Bari, Italy

2. Interventional and Medical Oncology Unit, IRCCS Istituto di Ricovero e Cura a Carattere Scientifico ‘Giovanni Paolo II’, I‑70124 Bari, Italy

3. Pharmacy Unit, IRCCS Istituto di Ricovero e Cura a Carattere Scientifico ‘Giovanni Paolo II’, I‑70124 Bari, Italy

4. Gynecology Unit, IRCCS Istituto di Ricovero e Cura a Carattere Scientifico ‘Giovanni Paolo II’, I‑70124 Bari, Italy

5. Medical Oncology Unit, IRCCS Istituto di Ricovero e Cura a Carattere Scientifico ‘Giovanni Paolo II’, I‑70124 Bari, Italy

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of rucaparib in patients with recurrent high-grade ovarian carcinoma: A systematic review and meta-analysis;Taiwanese Journal of Obstetrics and Gynecology;2024-09

2. Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship;European Journal of Medicinal Chemistry;2024-08

3. Crizotinib Enhances PARP Inhibitor Efficacy in Ovarian Cancer Cells and Xenograft Models by Inducing Autophagy;Molecular Cancer Research;2024-05-23

4. Targeted inhibition of the ATR/CHK1 pathway overcomes resistance to olaparib and dysregulates DNA damage response protein expression in BRCA2MUT ovarian cancer cells;Scientific Reports;2023-12-19

5. Machine Learning Quantification of Intraepithelial Tumor-Infiltrating Lymphocytes as a Significant Prognostic Factor in High-Grade Serous Ovarian Carcinomas;International Journal of Molecular Sciences;2023-11-07